My initial impression was that the company is doing too many acquisitions in a short span of time. But looks like there is a very clear strategy of seismic shift of focus towards mixing solutions, coz it opens up more avenues for the firm. I had a question on valuations – seems like there is a downwards trend in the stock since the last six months or so. Part reason is clearly the slowdown in mother industry for their largest revenue segment – chemical and pharma. Is there something else the market is factoring in?
Also – besides expanding avenues, is the focus on mixing solutions a part of managements plan to be less dependent on cyclicality in pharma and chemicals?
Expert views awaited – cheers!
| Subscribe To Our Free Newsletter |
